<DOC>
	<DOCNO>NCT01730495</DOCNO>
	<brief_summary>The hypothesis subset patient chronic fatigue syndrome/ myalgic encephalomyelitis ( CFS/ME ) , include also patient clinical response B-cell depletion therapy use anti-CD20 antibody Rituximab , may benefit tumor necrosis factor-alpha inhibition use Etanercept weekly subcutaneous injection .</brief_summary>
	<brief_title>Tumor Necrosis Factor-alpha Inhibition Using Etanercept Chronic Fatigue Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Encephalomyelitis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>chronic fatigue syndrome/ myalgic encephalomyelitis ( CFS/ME ) moderate serious CFS/ME severity age 1866 year informed consent patient fatigue , fulfil criterion CFS pregnancy lactation previous malignant disease , except basal cell carcinoma skin cervical carcinoma situ previous longterm systemic treatment immunosuppressive drug cyclosporine , azathioprin , mycophenolate mofetil , except steroid e.g . obstructive lunge disease . demyelinate disease , multiple sclerosis . heart failure . endogenous depression . lack ability comply protocol . multiallergy risk serious drug reaction reduce renal function ( creatinine &gt; 1.5 x UNL ) reduce liver function ( bilirubin transaminase &gt; 1.5 x UNL ) HIV positivity . Evidence clinically significant infection . Previous viral hepatitis risk reactivation . High risk opportunistic infection . Latent tuberculosis must treat inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Chronic fatigue syndrome</keyword>
	<keyword>CFS</keyword>
	<keyword>Myalgic Encephalomyelitis ( ME )</keyword>
	<keyword>CFS/ME</keyword>
	<keyword>Tumor necrosis factor-alpha</keyword>
	<keyword>TNF-alpha</keyword>
	<keyword>Etanercept</keyword>
</DOC>